Shikata K et al. |
Synthesis of non-natural C2-homo-ceramide and its apoptotic activity against HL-60 cells. |
2003 |
Bioorg. Med. Chem. Lett. |
pmid:12639542
|
De Jonghe S et al. |
Synthesis and apoptogenic activity of fluorinated ceramide and dihydroceramide analogues. |
1999 |
Bioorg. Med. Chem. Lett. |
pmid:10560744
|
Lin YC et al. |
Neuroprotective effects of furopyrazole derivative of benzylindazole analogs on C2 ceramide-induced apoptosis in cultured cortical neurons. |
2009 |
Bioorg. Med. Chem. Lett. |
pmid:19435666
|
Siskind LJ et al. |
Enlargement and contracture of C2-ceramide channels. |
2003 |
Biophys. J. |
pmid:12944273
|
Hisano N et al. |
Induction and suppression of endothelial cell apoptosis by sphingolipids: a possible in vitro model for cell-cell interactions between platelets and endothelial cells. |
1999 |
Blood |
pmid:10361127
|
Mansfield PJ et al. |
Regulation of polymorphonuclear leukocyte degranulation and oxidant production by ceramide through inhibition of phospholipase D. |
2002 |
Blood |
pmid:11830497
|
Yabu T et al. |
Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. |
2005 |
Blood |
pmid:15741222
|
Latinis KM and Koretzky GA |
Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. |
1996 |
Blood |
pmid:8562955
|
Posey SC et al. |
Failure of gelsolin overexpression to regulate lymphocyte apoptosis. |
2000 |
Blood |
pmid:10828033
|
Chen CL et al. |
Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. |
2008 |
Blood |
pmid:18270325
|
Suchard SJ et al. |
Ceramide inhibits IgG-dependent phagocytosis in human polymorphonuclear leukocytes. |
1997 |
Blood |
pmid:9058737
|
Mansfield PJ et al. |
Ceramide inhibition of phospholipase D and its relationship to RhoA and ARF1 translocation in GTP gamma S-stimulated polymorphonuclear leukocytes. |
2004 |
Blood |
pmid:14615385
|
Scheid MP et al. |
Ceramide and cyclic adenosine monophosphate (cAMP) induce cAMP response element binding protein phosphorylation via distinct signaling pathways while having opposite effects on myeloid cell survival. |
1999 |
Blood |
pmid:9864164
|
Pruschy M et al. |
Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells. |
1999 |
Br. J. Cancer |
pmid:10360645
|
Perks CM et al. |
Prolactin acts as a potent survival factor for human breast cancer cell lines. |
2004 |
Br. J. Cancer |
pmid:15213724
|
Perks CM et al. |
Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines. |
1999 |
Br. J. Cancer |
pmid:10070857
|
Sugiki H et al. |
C2-ceramide induces apoptosis in a human squamous cell carcinoma cell line. |
2000 |
Br. J. Dermatol. |
pmid:11122015
|
Di Nardo A et al. |
Ceramide 2 (N-acetyl sphingosine) is associated with reduction in Bcl-2 protein levels by Western blotting and with apoptosis in cultured human keratinocytes. |
2000 |
Br. J. Dermatol. |
pmid:10971319
|
Czyborra P et al. |
Transient relaxation of rat mesenteric microvessels by ceramides. |
2002 |
Br. J. Pharmacol. |
pmid:11815377
|
Won JS et al. |
Stimulation of astrocyte-enriched culture with C2 ceramide increases proenkephalin mRNA: involvement of cAMP-response element binding protein and mitogen activated protein kinases. |
2001 |
Brain Res. |
pmid:11382404
|